Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

Clinical trial NCT05321810 · COMPLETED

Trial details

NCT number: NCT05321810
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Non-valvular Atrial Fibrillation

Start date: 2022-04-15
Primary completion: 2022-04-15
Enrollment: 193565

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.